Clinical trial
An Open-label, 8-Week Study to Compare the Comfort and Ease of Use of Five Different Treatment Regimens for CNTX-4975-05 Intra-articular Injection in Subjects With Chronic, Moderate-to-Severe Osteoarthritis Knee Pain
NCT03661996 is registered in ClinicalTrials.gov with Centrexion Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-label, 8-Week Study to Compare the Comfort and Ease of Use of Five Different Treatment Regimens for CNTX-4975-05 Intra-articular Injection in Subjects With Chronic, Moderate-to-Severe Osteoarthritis Knee Pain
- Lead sponsor
- Centrexion Therapeutics
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 18, 2018
- Completion date
- October 22, 2019
- Enrollment
- 854 (actual)
- Sites
- 28
Conditions
As the registry lists them; a condition with its own page is linked.
knee osteoarthritis